GlassScriptPhysician profile
Amy Duncan
NPI 1568862951
$5,682.30
in general payments reported to CMS, 2019-2025
33 companies · $1,372 in 2025
The $1,372 reported for 2025 was more than what 91% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $536 · 2022: $1,129 · 2023: $1,064 · 2024: $1,581 · 2025: $1,372.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,017.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,017.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,395.50 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $585.86 | 2021-2025 | Eliquis, Camzyos |
| Pfizer INC. | $498.14 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $407.86 | 2021-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $381.38 | 2022-2025 | Verquvo, Capvaxive, Lagevrio |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $366.63 | 2022-2025 | Lifevest |
| Amgen INC. | $301.30 | 2022-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $159.13 | 2022-2024 | Xarelto |
| Medtronic, INC. | $152.50 | 2022-2025 | Linq II |
| Philips North America LLC | $150.87 | 2023-2025 | Ecc Solutions, (Ck4) Mcot, (Ck7) Extended Holter |
| Sanofi-Aventis U.S. LLC | $150.66 | 2022-2023 | |
| Astrazeneca Pharmaceuticals LP | $147.88 | 2021-2025 | Farxiga, Wainua, Brilinta |
| Edwards Lifesciences Corporation | $130.12 | 2022 | |
| Inari Medical, INC. | $98.13 | 2024-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Cvrx, INC. | $95.46 | 2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Irhythm Technologies, INC. | $91.56 | 2024 | Zio Xt Patch, Zio Monitor |
| Boston Scientific Corporation | $81.73 | 2023-2025 | General - Crm_crm, Lithovue, Watchman Access System |
| Abbott Laboratories | $73.77 | 2023-2024 | Cardiomems |
| Scpharmaceuticals INC. | $59.87 | 2025 | |
| Alnylam Pharmaceuticals INC. | $49.92 | 2024-2025 | Onpattro |
| Chiesi USA, INC. | $43.15 | 2023-2025 | Kengreal, Cleviprex |
| Kiniksa Pharmaceuticals International, Plc | $43.08 | 2024 | Arcalyst |
| Stryker Corporation | $33.60 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Heartflow, INC. | $32.40 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $31.52 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $16.87 | 2022 | |
| Glaxosmithkline, LLC. | $16.06 | 2025 | Arexvy |
| Becton, Dickinson and Company | $15.85 | 2025 | |
| Atricure, INC. | $15.11 | 2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Shockwave Medical, INC | $14.78 | 2022 | |
| Davol INC. | $14.28 | 2025 | Arista |
| Kiniksa Pharmaceuticals, LTD. | $13.74 | 2022 | |
| Inspire Medical Systems, INC. | $13.59 | 2024 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Duncan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.